However, our study showed that the functional impairment of CD3+CD56+ NKT-like cells was not rescued following TGF-β1 blockade, suggesting other soluble factor's involvement from tumor microenvironment rather than TGF-β1. This evidence concerns the gene NCAM1 and neoplasm.